SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-002946
Filing Date
2024-05-17
Accepted
2024-05-16 18:45:31
Documents
6
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_051524.htm 6-K 6119
2 EXHIBIT 99.1 exh_991.htm EX-99.1 348726
3 EXHIBIT 99.2 exh_992.htm EX-99.2 184944
4 EXHIBIT 99.3 exh_993.htm EX-99.3 9817
5 EXHIBIT 99.4 exh_994.htm EX-99.4 9820
6 GRAPHIC logo.jpg GRAPHIC 7882
  Complete submission text file 0001171843-24-002946.txt   571465
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 24957244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)